Cover Image

Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Marek Pásek, Jindřich Kopecký, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma
by: Theo Marguet, et al.
Published: (2024)

Melanosis and isolated follicular vitiligo during checkpoint inhibitors for metastatic melanoma
by: Valentine Salvestrini, et al.
Published: (2024)

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
by: Dirk Tomsitz, et al.
Published: (2025)

Impact of melanoma histological regression on first‐line immunotherapy response in stage‐IV disease
by: Jean‐Baptiste Such, et al.
Published: (2025)

Adjuvant treatment for acral melanoma
by: Takaya Komori, et al.
Published: (2026)

Age‐associated metastatic potential of melanoma in lymph nodes: A preliminary gene association study
by: C. C. Zouboulis, et al.
Published: (2024)

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti‐ PD ‐1 immunotherapy
by: Renan de Jesus Teixeira, et al.
Published: (2025)

Evaluation of combination therapy with ofatumumab and systemic corticosteroids for pemphigus: A multi‐centre cohort study
by: Jing Mao, et al.
Published: (2024)

Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients
by: Samy Belkaïd, et al.
Published: (2025)

Differential predictive value of tissue‐specific PD‐L1 expression scores in adjuvant immunotherapy of melanoma
by: Glenn Geidel, et al.
Published: (2024)

The need to prevent corticosteroid‐induced myopathy in patients with autoimmune bullous skin diseases
by: Pascal Joly
Published: (2025)

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas
by: Damien Sanogo, et al.
Published: (2025)

Should systemic corticosteroids be relatively contraindicated in granuloma annulare?
by: Max E. Oscherwitz, et al.
Published: (2024)

European expert consensus statement on the systemic treatment of alopecia areata
by: L. Rudnicka, et al.
Published: (2024)

Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients
by: S. E. B. Feldborg, et al.
Published: (2024)

Topical corticosteroids in the era of new topical therapies: Balancing efficacy and safety for long‐term use
by: Alexander Egeberg, et al.
Published: (2024)

Redefining skin toxicity in the age of precision immunotherapy
by: Florentia Dimitriou, et al.
Published: (2026)

Cutaneous melanoma in adolescents and young adults
by: Alessandra Buja, et al.
Published: (2024)

Excellent response to cemiplimab and radiotherapy in advanced metastatic porocarcinoma
by: Nessr Abu Rached, et al.
Published: (2024)

Tocilizumab for severe and refractory mucous membrane pemphigoid
by: Billal Tedbirt, et al.
Published: (2026)

Melanocytic clefting is associated with melanoma on LC ‐ OCT
by: J. Pérez‐Anker, et al.
Published: (2025)

Advancing AI models for enhanced melanoma diagnosis
by: François Kuonen, et al.
Published: (2025)

Moles and melanomas on tattoos: Where we are in 2025
by: Nicolas Kluger
Published: (2025)

The quest for missing risk factors to predict melanoma
by: M. Wakkee, et al.
Published: (2025)

Treatment of progressive locally advanced and metastatic basal cell carcinoma after two lines of treatment with hedgehog inhibitors and anti‐PD1: The role of sonidegib rechallenge
by: L. Ambrosio, et al.
Published: (2025)

Precision medicine in cutaneous melanoma—A comprehensive review
by: Markus Reitmajer, et al.
Published: (2025)

MAPK activity as a surrogate of acral melanoma immunogenicity?
by: Rastine Merat
Published: (2025)

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma
by: Inga Hansen, et al.
Published: (2024)

Control of rapidly progressing melanoma metastases during pregnancy
by: Isabel Wolff, et al.
Published: (2025)

Family history in melanoma risk: Revisiting criteria for surveillance
by: Annemiek Leeman, et al.
Published: (2025)

Diving beyond surface perceptions of melanoma diagnosis and screening
by: Efthymia Soura, et al.
Published: (2024)

Comments on ‘Higher cumulative dose of topical corticosteroids is associated with osteoporosis and major osteoporotic fracture: A nationwide case–control study’
by: Wei‐Min Chu, et al.
Published: (2024)

Effect of patient‐contextual skin images in human‐ and artificial intelligence‐based diagnosis of melanoma: Results from the 2020 SIIM‐ISIC melanoma classification challenge
by: Nicholas R. Kurtansky, et al.
Published: (2024)

Pregnancy‐associated melanoma: A distinct entity requiring vigilance
by: Maria Kostaki, et al.
Published: (2026)

Age matters: Rethinking SLNB's reliability in melanoma mortality prediction
by: Christoffer Gebhardt
Published: (2024)

Pregnancy‐associated melanoma epidemiology: A multicentre European study
by: Maria Kostaki, et al.
Published: (2025)

Acral melanoma: Molecular subtyping as a gateway to precision medicine
by: Emi Dika, et al.
Published: (2025)

Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series
by: Liting Cai, et al.
Published: (2024)

Melanocytic clefting in melanoma: Reassessing its role in diagnostic decision‐making
by: Shiuan‐Chih Chen, et al.
Published: (2025)

Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study
by: Eftychia Chatziioannou, et al.
Published: (2025)